Journal of Inherited Metabolic Diseases

JIMD Podcasts is home to the Journal of Inherited Metabolic Disease podcast and the JIMD Shortcast. We're also proud to showcase Metabolic Mysteries and the new Footprints in IMD podcast.

‍

Visit podcast website

Download MedPod Learn

Make more of your medical podcast listening. Browse and listen free in MedPod Learn; Premium adds structured notes, self-test questions, reflection and exportable learning records.
This website provides podcast information and episode previews.
Try MedPod’s learning tools with a St Emlyn’s sample
October 27, 2026

Methionine synthase: Location matters

Methionine synthase operates within the nucleus as well as the cytoplasm and interacts with proteins involved in DNA methylation. These findings suggest compartment-specific one-carbon metabolism, although direct substrate channelling and protection in cobalamin disorders remain unproven.

October 23, 2026

Shortcast: Glut1-Deficiency Syndrome: New Insights From a Brazilian Cohort of Patients

GLUT1 deficiency can cause epilepsy, movement disorders and language difficulties despite normal blood glucose. A Brazilian cohort highlights delayed diagnosis, variable expression within families, ketogenic diet benefits beyond seizure control and an exploratory severity score requiring further validation.

October 20, 2026

Shortcast: Challenges in Managing Pregnancy in Patients With Fructose 1, 6-Bisphosphatase Deficiency

Pregnancy increases vulnerability to hypoglycaemia and lactic acidosis in fructose 1,6-bisphosphatase deficiency, particularly when oral intake falls. Gestational diabetes complicates glucose management, requiring coordinated nutritional planning and continued monitoring after delivery.

October 14, 2026

Citrin deficiency: changing presentations, challenging assumptions

Citrin deficiency can present with neonatal cholestasis, childhood abdominal symptoms and growth difficulties, or later hyperammonaemia. Normal citrulline after infancy does not exclude the diagnosis, while carbohydrate intolerance and condition-specific emergency treatment require particular attention.

October 7, 2026

IMD Research Round-Up: HFI & fructose metabolism

Hereditary fructose intolerance can remain undiagnosed into adulthood when patients instinctively avoid sweet foods. Fructose and sorbitol restriction remain central, while early ketohexokinase-inhibitor research offers preliminary insights into treatment and fatty liver mechanisms.

October 1, 2026

Shortcast: Characterization of Adult Patients With Neurometabolic Disorders

Adults with inherited neurometabolic disorders have diverse clinical and social needs. Childhood disease onset is not the same as childhood diagnosis, disease-specific treatments are common in this specialist cohort, and absence of formal support does not establish functional independence.

September 29, 2026

Shortcast: Neonatal Acute Liver Failure due to Citrin Deficiency (NALFCD)

Citrin deficiency can produce neonatal acute liver failure without cholestasis and mimic citrullinaemia type 1 on newborn screening. Worsening synthetic function during high-carbohydrate treatment should prompt diagnostic review and rapid nutritional redirection.

September 23, 2026

The Clinical Chameleons: Rethinking Remethylation Disorders

Remethylation disorders can present with neurological, psychiatric, eye or renal disease across the age range; total homocysteine, methionine, methylmalonic acid, vitamin B12, holotranscobalamin and folate help distinguish vitamin deficiency from inherited metabolic disease.

September 18, 2026

Metabolic Mysteries: Progressive neurological decline, equivocal biomarkers, negative genetics!

Progressive ataxia, dysarthria and vertical supranuclear gaze palsy can remain diagnostically unresolved despite negative exome sequencing; evolving biomarkers and RNA sequencing from cultured fibroblasts may reveal deep intronic splicing abnormalities missed by conventional DNA testing.

September 14, 2026

Metabolic Mysteries: Ataxia, tremor and a normal vitamin B12

Progressive ataxia, tremor, seizures and spinal MRI evidence of subacute combined degeneration can signal late-onset cobalamin C disease despite normal serum vitamin B12, prompting methylmalonic acid, homocysteine and targeted metabolic investigation.